Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT03934372
Title	Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors
Recruitment	Recruiting
Gender	both
Phase	Phase Ib/II
Variant Requirements	Yes
Sponsors	Incyte Biosciences International Sarl
Indications	Advanced Solid Tumor lymphoma acute myeloid leukemia acute lymphoblastic leukemia central nervous system cancer leukemia chronic myeloid leukemia
Therapies	Ponatinib
Age Groups:	child
Covered Countries	SWE \| NLD \| ITA \| GBR \| FRA \| ESP \| DNK \| DEU \| BEL